Presentation is loading. Please wait.

Presentation is loading. Please wait.

Kuhlmann et al. Suppl. Figure 4 A bisulfite sequencing CG CHG CHH Δ open: unmethylated filled: methylated.

Published byLauren O'Neill Modified over 10 years ago

Similar presentations

Presentation on theme: "Kuhlmann et al. Suppl. Figure 4 A bisulfite sequencing CG CHG CHH Δ open: unmethylated filled: methylated."— Presentation transcript:

1 Kuhlmann et al. Suppl. Figure 4 A bisulfite sequencing CG CHG CHH Δ open: unmethylated filled: methylated

2 Kuhlmann et al. Suppl. Figure 4 B bisulfite sequencing CG CHG CHH Δ open: unmethylated filled: methylated

3 Kuhlmann et al. Suppl. Figure 4 C bisulfite sequencing CG CHG CHH Δ open: unmethylated filled: methylated

4 Kuhlmann et al. Suppl. Figure 4 D bisulfite sequencing CG CHG CHH Δ open: unmethylated filled: methylated

5 Kuhlmann et al. Suppl. Figure 4 E bisulfite sequencing CG CHG CHH Δ open: unmethylated filled: methylated

6 Kuhlmann et al. Suppl. Figure 4 F bisulfite sequencing CG CHG CHH Δ open: unmethylated filled: methylated

7 Kuhlmann et al. Suppl. Figure 4 G bisulfite sequencing CG CHG CHH Δ open: unmethylated filled: methylated

8 Kuhlmann et al. Suppl. Figure 4 H bisulfite sequencing CG CHG CHH Δ open: unmethylated filled: methylated

9 Kuhlmann et al. Suppl. Figure 4 I bisulfite sequencing CG CHG CHH Δ open: unmethylated filled: methylated

10 Kuhlmann et al. Suppl. Figure 4 J bisulfite sequencing CG CHG CHH Δ open: unmethylated filled: methylated

11 Kuhlmann et al. Suppl. Figure 4 K bisulfite sequencing CG CHG CHH Δ open: unmethylated filled: methylated

12 Kuhlmann et al. Suppl. Figure 4 L bisulfite sequencing CG CHG CHH Δ open: unmethylated filled: methylated

13 Kuhlmann et al. Suppl. Figure 4 M bisulfite sequencing CG CHG CHH Δ open: unmethylated filled: methylated

14 Kuhlmann et al. Suppl. Figure 4 N bisulfite sequencing CG CHG CHH Δ open: unmethylated filled: methylated

15 Kuhlmann et al. Suppl. Figure 4 O bisulfite sequencing CG CHG CHH Δ open: unmethylated filled: methylated

16 Kuhlmann et al. Suppl. Figure 4 P bisulfite sequencing CG CHG CHH Δ open: unmethylated filled: methylated

17 Kuhlmann et al. Suppl. Figure 4 Q bisulfite sequencing CG CHG CHH Δ open: unmethylated filled: methylated

18 Kuhlmann et al. Suppl. Figure 4 R bisulfite sequencing CG CHG CHH Δ open: unmethylated filled: methylated

Download ppt "Kuhlmann et al. Suppl. Figure 4 A bisulfite sequencing CG CHG CHH Δ open: unmethylated filled: methylated."

Similar presentations

P

P
Kuhlmann et al. Suppl. Figure 1. Kuhlmann et al. Suppl. Figure 2 SRA-domainSET-domain Gabi-Kat_516A07 SALK_079574 At2g33290 SUVH2 SRA-domainSET-domain.

Kuhlmann et al. Suppl. Figure 1. Kuhlmann et al. Suppl. Figure 2 SRA-domainSET-domain Gabi-Kat_516A07 SALK_ At2g33290 SUVH2 SRA-domainSET-domain.
Functional Genomics with Next-Generation Sequencing

Functional Genomics with Next-Generation Sequencing
The Build-up of the Red Sequence at z

The Build-up of the Red Sequence at z
Epigenetics Xiaole Shirley Liu STAT115, STAT215, BIO298, BIST520.

Epigenetics Xiaole Shirley Liu STAT115, STAT215, BIO298, BIST520.
Estrogen and its receptors play an important role in breast carcinogenesis. In humans, there are two subtypes of estrogen receptors (ER), ER  and ER ,

Estrogen and its receptors play an important role in breast carcinogenesis. In humans, there are two subtypes of estrogen receptors (ER), ER  and ER ,
P247. Figure 9-1 p248 Figure 9-2 p251 p251 Figure 9-3 p253.

P247. Figure 9-1 p248 Figure 9-2 p251 p251 Figure 9-3 p253.
Epigenetics Lab December 1, 2008 Goals of today’s lab: 1.Understand the basic molecular techniques used in the lab to study epigenetic silencing in cancer.

Epigenetics Lab December 1, 2008 Goals of today’s lab: 1.Understand the basic molecular techniques used in the lab to study epigenetic silencing in cancer.
OFFICE OF CYBER INFRASTRUCTURE AND COMPUTATIONAL BIOLOGY NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES MEseq, a software package for bisulfite.

OFFICE OF CYBER INFRASTRUCTURE AND COMPUTATIONAL BIOLOGY NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES MEseq, a software package for bisulfite.
High-throughput bisulfite sequencing reveals relationships between gene expression and DNA methylation in the bivalve, Crassostrea gigas Mackenzie Gavery.

High-throughput bisulfite sequencing reveals relationships between gene expression and DNA methylation in the bivalve, Crassostrea gigas Mackenzie Gavery.
SKOV3 ~44% SKBR3 ~6% SiHa ~89% CaSki i ~67% HeLa ~89% Supplementary Figure 1 Huisman et al Supplementary Figure 1. DNA methylation status of the EPB41L3.

SKOV3 ~44% SKBR3 ~6% SiHa ~89% CaSki i ~67% HeLa ~89% Supplementary Figure 1 Huisman et al Supplementary Figure 1. DNA methylation status of the EPB41L3.
GDNA mix AA/(AA+GG) (A) Takeda et al., Supplemental Figure 1 (C) Sequence Height A / (A+G) Sequence Height A / (A+G) Sequence Height A / (A+G) (B) (D)

GDNA mix AA/(AA+GG) (A) Takeda et al., Supplemental Figure 1 (C) Sequence Height A / (A+G) Sequence Height A / (A+G) Sequence Height A / (A+G) (B) (D)
Ab c Ahmed Supplementary Figure 1. ba CG GC CHG GHC Ahmed Supplementary Figure 2 c d Methylation difference -log(p-value)

Ab c Ahmed Supplementary Figure 1. ba CG GC CHG GHC Ahmed Supplementary Figure 2 c d Methylation difference -log(p-value)
Dataset S1 – KvDMR bisulphite cloning analysis Bisulphite PCR products containing 23 CpG dinucleotides were cloned and sequenced from human EB trophoblast.

Dataset S1 – KvDMR bisulphite cloning analysis Bisulphite PCR products containing 23 CpG dinucleotides were cloned and sequenced from human EB trophoblast.
Nat. Rev. Endocrinol. doi: /nrendo

Nat. Rev. Endocrinol. doi: /nrendo
Figure S3. Absence of DNA methylation in pre-cancerous thymocytes

Figure S3. Absence of DNA methylation in pre-cancerous thymocytes
Figure 1. MORT gene silencing is early event in cancer

Figure 1. MORT gene silencing is early event in cancer
FECH gene marker site (Single-plex assay design)

FECH gene marker site (Single-plex assay design)
Structures of CK1 inhibitors and their effects on CK1 activity in vitro. Structures of CK1 inhibitors and their effects on CK1 activity in vitro. (A) Structures.

Structures of CK1 inhibitors and their effects on CK1 activity in vitro. Structures of CK1 inhibitors and their effects on CK1 activity in vitro. (A) Structures.
Checklist for Site Reconnaissance (Sabatini et al_2002)

Checklist for Site Reconnaissance (Sabatini et al_2002)

Similar presentations

Ads by Google